The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma.

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q40416320

about

Recent Insights into Cell Surface Heparan Sulphate Proteoglycans and Cancer Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma Current status and perspectives of immune-based therapies for hepatocellular carcinoma Current concepts in the immunohistochemical evaluation of liver tumors Systemic therapy of hepatocellular carcinoma: current status and future perspectives Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin GPC-3 in hepatocellular carcinoma: current perspectives Glypican-2 levels in cerebrospinal fluid predict the status of adult hippocampal neurogenesis.Liver metastasis from hepatoid adenocarcinoma of the esophagus mimicking hepatocellular carcinoma.Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma.Liverome: a curated database of liver cancer-related gene signatures with self-contained context information Expression of glypican 3 in placental site trophoblastic tumor.Validation of glypican-3-specific scFv isolated from paired display/secretory yeast display library.Glypican-3: a new target for cancer immunotherapy.Histopathology of hepatocellular carcinoma Glypican-1 regulates anaphase promoting complex/cyclosome substrates and cell cycle progression in endothelial cells.Peeling off the hidden genetic heterogeneities of cancers based on disease-relevant functional modules.Seminal vesicle metastasis after partial hepatectomy for hepatocellular carcinoma Molecular pathology of hepatic neoplasms: classification and clinical significance.The Applicability of a Human Immunohistochemical Panel to Mouse Models of Hepatocellular Neoplasia.Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma.Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges.Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma.Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation.Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients.Dysplastic nodules with glypican-3 positive immunostaining: a risk for early hepatocellular carcinoma.Glypican-3 antibodies: a new therapeutic target for liver cancer.Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma.Characterization of a new monoclonal anti-glypican-3 antibody specific to the hepatocellular carcinoma cell line, HepG2.Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma.Pathology for the HPB Surgeon.An Overview of Biomarkers and Molecular Signatures in HCC.Cytokeratin 20-positive hepatocellular carcinoma.Assessment of stromal invasion for correct histological diagnosis of early hepatocellular carcinoma.Impaired autophagy response in human hepatocellular carcinoma.

P2860

Q26740617-996E06D9-8048-495E-B0D6-72E690CCB720 Q26743361-ACD49637-D24A-4F3F-9DA9-E09E093F3CCA Q26772321-C40475C6-6732-43D8-96B0-6AF049EC48E3 Q26772326-189F0C63-EB74-47B2-90E4-2EAAF1220A2F Q26864205-F44B9F8A-38CE-4D61-8F0A-25A251D5CBF2 Q26865844-A53500C7-F4C6-4E87-AB58-8775D22DBC8B Q27015134-F13A2772-9E92-465A-8ABB-6EAD6CF2DBAA Q28066774-8A1C24B5-01EE-46A2-9997-AA1057D8B889 Q33601245-06974C14-C772-4728-AA27-DEB407D60CC4 Q33726816-9DB32003-297F-4FD3-9943-2041C0DE4C1F Q33914169-538B3257-1A23-4497-B3FC-A5F68C5E6D33 Q34173509-BFDA6372-7AEE-4361-8CE7-2E11CB835B66 Q34199179-7BA1B520-D90C-47D8-87F8-CA9436EBD8EA Q34260503-7CEAB67E-048D-499F-AB66-8EFCFA43B79E Q34543102-137433D8-01FE-4D1B-9C35-01299314353F Q34552007-7F34E39C-5D77-499D-AC75-208811F0D7B8 Q34770477-37981732-90C6-4B35-BE78-9C2A20DDD67C Q34809541-22BA126B-9810-4598-90C0-86D4B46A9E9D Q34818437-36FD9EDE-F80B-4E0A-9F61-833F7830112B Q34954493-84B36EC4-A1DC-4014-A6E6-23369AF6D6A8 Q36197579-D7563247-52FA-4DFE-9082-280E45B894A6 Q36561628-2FB8A26F-08E7-4336-B6E1-0DC23136CF36 Q36598885-9BE32683-01F4-4DB9-BF0A-A7B42389B2A4 Q36712597-B5DA477B-E6CB-42E2-9981-E0B090F72192 Q36716630-071802A9-3938-4CE5-915B-BF102B12EA9E Q36787608-39B28BC0-7CE3-4264-81BE-148C4BB80438 Q36802501-0FFA097A-FE9B-45D7-9762-E005BD9D6B17 Q37031710-7106F49D-B47C-4201-88E8-3BAA34CE770A Q37278475-53571240-892B-40F7-89E2-240D28C592E8 Q37299042-605A7E63-E093-4402-88C8-6AC8A067356E Q37538453-5F0EF7E9-D320-45C2-9FE1-8E351982AE94 Q37625736-00B2E9B0-4789-40E6-970E-202BA661BB93 Q37625957-C22A3476-C932-43C9-AA56-96CA09632989 Q37685728-2F19B133-F48E-4AD9-B50A-5DAFF902F7B8 Q37688462-FD75F948-5226-4387-88AA-7F3C3CA44DF1 Q38078346-F8E94F3E-9C01-49C6-A926-7B0A5C2488D1 Q38166571-25868A43-16E8-434B-B995-0B1420030CC7 Q38313857-E84CE1F7-F2EF-46C6-9540-D2F17159D940 Q38367782-D81D1683-39F5-4A54-B5DB-EB9EF15805B6 Q38393661-8A89A7E5-BD57-4003-88DA-73672B99D55B

P2860

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q40416320

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

The glypican 3 oncofetal prote ...... for hepatocellular carcinoma.

@en

type

label

The glypican 3 oncofetal prote ...... for hepatocellular carcinoma.

@en

prefLabel

The glypican 3 oncofetal prote ...... for hepatocellular carcinoma.

@en

P1433

Q40416320-A140FFE5-F931-41F6-AFD9-EBC66A90ED12

P1476

Q40416320-4A4D06EF-4A3B-432C-AD9C-55855845C848

P2093

Q40416320-03F3FEA4-ED38-4860-A358-B21E5A1830D9

Q40416320-63EF633C-CE42-4C45-9533-99A2839B8625

Q40416320-66E58889-638B-4D66-AFA9-C9C37619A970

Q40416320-6BFD32C2-B180-456C-B0D0-82B9F94AAC77

Q40416320-78380671-9D62-4283-BAD5-7B006F096F20

Q40416320-7B0F8B34-1BF6-4340-A675-A65454AE0E12

Q40416320-7C090705-40D6-4887-BED7-7AE1F2A430D4

Q40416320-83F6399D-F82E-4750-A607-C5739B40E98E

Q40416320-8B4FA646-B37A-4699-BD45-9C3484765032

Q40416320-8F65CC62-2210-4BE2-82E9-59D414C75794

P2860

Q40416320-1E88D917-11AD-4454-966C-714D55AFBA3C

Q40416320-277A0621-A53B-4379-8346-D9138B329416

Q40416320-4B033B06-E267-44A6-B9BB-32C6DDB52D56

Q40416320-546EFDC6-2781-4513-9C44-A3619AC1A0EF

Q40416320-6522D1C5-4C30-4CF4-8E6C-BC40A333F09F

Q40416320-663961EB-6A23-46D3-978C-462A23325221

Q40416320-7CBB9B9B-EB73-46B9-AA7F-78A9F5369057

Q40416320-7EF0FFB2-BDDB-4908-A30C-9C695169200A

Q40416320-82C79A61-EA63-4AB9-B9A2-B0781B2562E7

Q40416320-9119BEBC-F5B7-4B89-9C20-D4D74172AD04

P2888

Q40416320-9D62993F-7C5F-439E-8B75-C3FBF843933A

P304

Q40416320-F125A34A-77A8-4B9B-8298-BFA035405324

P31

Q40416320-ECB1AAEB-6405-42DC-B48E-ABBA599F4119

P356

Q40416320-49FAAD39-07A4-41C0-9DB9-C26126D7EFF4

P433

Q40416320-45172FEE-8B3D-4D42-AA36-FEF0994D478B

P478

Q40416320-0078578B-169F-4905-8C60-CB80EDD16391

P577

Q40416320-B16F03D8-7418-4B8C-AAED-DA9B31EC0665

P5875

Q40416320-2F1543DA-0A2C-4196-A668-50CF1D4888BF

P6179

Q40416320-6B13A2BA-5801-4177-8F1C-A11288547FD9

P698

Q40416320-EA3DA004-441C-40C5-AFB4-166E30C0F4F0

P356

MODPATHOL.3800436

P1433

Modern Pathology

P1476

The glypican 3 oncofetal prote ...... for hepatocellular carcinoma.

@en

P2093

Akira Watanabe

http://www.w3.org/2001/XMLSchema#string

Hiroko Iwanari

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Aburatani

http://www.w3.org/2001/XMLSchema#string

Junji Shibahara

http://www.w3.org/2001/XMLSchema#string

Ken-Ichi Ohashi

http://www.w3.org/2001/XMLSchema#string

Masashi Fukayama

http://www.w3.org/2001/XMLSchema#string

Masatoshi Makuuchi

http://www.w3.org/2001/XMLSchema#string

Masaya Mori

http://www.w3.org/2001/XMLSchema#string

Michiyo Hishinuma

http://www.w3.org/2001/XMLSchema#string

Naoko Yamauchi

http://www.w3.org/2001/XMLSchema#string

P2860

glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development

Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis

Hepatocellular carcinoma.

Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.

Glypicans: proteoglycans with a surprise.

Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders

OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.

Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.

OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2.

Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy.

P2888

modpathol.3800436

P304

1591-1598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.3800436

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7820423

http://www.w3.org/2001/XMLSchema#string

P6179

1027594159

http://www.w3.org/2001/XMLSchema#string

P698

15920546

http://www.w3.org/2001/XMLSchema#string